Craft

Yew Bio-Pharm

Stock Price

$0

2023-11-09

Market Capitalization

$11.8 K

2023-11-09

Revenue

$27.3 M

FY, 2020

Yew Bio-Pharm Summary

Company Summary

Overview
Yew Bio-Pharm Group, Inc., through its operating entity, Harbin Yew Science and Technology Development Co., Ltd (HDS), is grower and seller of yew materials used to produce traditional Chinese medicines (TCMs), yew trees and yew handicrafts in China.
Type
Public
Status
Active
Founded
2007
HQ
Las Vegas, NV, US | view all locations
Website
http://www.yewbiopharm.com/
Cybersecurity rating
Sectors

Key People

  • Zhiguo Wang, Chairman & Chief Executive Officer

    • Guifang Qi, Treasurer & Director

      LocationsView all

      2 locations detected

      • Las Vegas, NV HQ

        United States

        294 Powerbilt Ave

      • Haerbin Shi, Heilongjiang Sheng

        China

        18 Hengshan Rd, Xiangfang Qu

      Yew Bio-Pharm Financials

      Summary Financials

      Revenue (Q3, 2021)
      $110.1K
      Gross profit (Q3, 2021)
      ($840.1K)
      Net income (Q3, 2021)
      ($1.6M)
      Cash (Q3, 2021)
      $28.5K
      EBIT (Q3, 2021)
      ($1.6M)
      Enterprise value
      $9.2M

      Footer menu